People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biostage, Inc. | — | Biotechnology | Series A | $36.5M | $1.8M | 2016 |
John Canepa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Canepa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Green | 1 | 8 |
| John Kennedy | 1 | 6 |
| Thomas Robinson | 1 | 3 |
| Wei Zhang | 1 | 3 |
| Jing Chen | 1 | 3 |
| Thomas McNaughton | 1 | 2 |
| Ronald Packard | 1 | 2 |
| Ting Li | 1 | 2 |
| Blaine McKee | 1 | 2 |
| James Shmerling | 1 | 1 |
| Shunfu Hu | 1 | 1 |
| Jeffrey Young | 1 | 1 |
| Matthew Dallas | 1 | 1 |
| Peter Chakoutis | 1 | 1 |
| La Francesca Saverio | 1 | 1 |
| James McGorry | 1 | 1 |
| William Fodor | 1 | 1 |
| Junli He | 1 | 1 |
| Hong Yu | 1 | 1 |
| Mao Zhang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.